24EL-416 On-Demand eCast: Navigating Clinical Trials - Quality Agreement Essentials for Cell Processing Facilities

Live Program Date: Wednesday, March 20, 2024
Program Number: 24EL-416

Educational Track: Quality Education
Topics: Biotherapies
Intended Audience: CEOs, CFOs, Directors, Donor Recruitment Staff, Hospital Blood Banks, Hospitals, Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Physicians, Research Scientists, Residents/Fellows, Scientists, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
Teaching Level: Advanced, Intermediate

Faculty
(titles and affiliations at the time of the live program)
Director/Moderator: Wanxing Cui, MD, PhD, CABP(H), Director, Cell Therapy Manufacturing Facility, MedStar Georgetown University Hospital, Washington, DC
Speakers: Aisha Khan, PhD, MBA, Executive Director, Laboratory Operations, Interdisciplinary Stem Cell Institute, University of Miami, Miami, FL; Ronit Slotky, PhD, MSc, CABP, Director, Cell Therapies Manufacturing Facility, Hackensack University Medical Center; Professor of Oncology, Hackensack Meridian School of Medicine, Hackensack, NJ; Suzanne Thibodeaux, MD, PhD, CABP(H), Section Head, Blood Bank/Apheresis/CTL/HLA, Washington University School of Medicine St. Louis, St. Louis, MO

Program Description
The rapidly evolving field of cell therapy has positioned clinical trials as the critical conduit to groundbreaking treatments, transforming the future of patient care. Within this intricate framework, quality agreements emerge as the cornerstone, ensuring that every facet of these trials adheres to the highest standards of safety, efficacy, and compliance. These agreements not only set the benchmarks but also act as the guiding compass, ensuring that all stakeholders, from researchers to cell processing facilities, navigate the clinical trial landscape with precision and expertise.

This eCast delves into the heart of clinical trials, shedding light on the pivotal role of quality agreements. Through discussions, demonstrations, and case studies, attendees will gain insights into the structure and significance of these agreements. The program will explore how quality agreements influence the course of clinical trials and provide cell processing facilities with the tools and knowledge to stay at the forefront of best practices. By emphasizing the importance of these agreements in the broader context of cell therapy clinical trials, this program aims to equip attendees with a nuanced understanding, preparing them for the challenges and opportunities that lie ahead.

Learning Objectives
After participating in this educational activity, participants should be able to:

• Describe the essence of quality agreements in clinical trials.
• Discuss the components of quality agreements for clinical trials.
• Optimize clinical trial navigation with quality agreements.
• Enhance communication and collaboration through quality agreements.
• Address clinical trial challenges using quality agreement frameworks.

How to Claim Continuing Education Credit

• Single Viewers: if you registered as a single viewer, complete the evaluation found on the "CE Information" tab after watching the video. By submitting the evaluation, you are attesting to watching the presentation in its entirety.

• Group Viewers: This is applicable for groups/facilities that purchased Group Viewing access for this program (registration will be verified prior to processing a group viewing attendance log). Group Viewing Coordinators should submit the attendance log to eLearning@aabb.org within 72 hours of the completion/viewing date. Once AABB receives an attendance log, each participant on the attendance log will be granted access as a single viewer to this program and will be required to complete the evaluation in order to claim continuing education credit. Each participant will be required to have an AABB account in order to access this program/platform. If a participant does not have an account, he/she can create one using the same email address provided on the attendance log.